Table 6.
Regression analysis on the effect of prolactin upon hormonal and metabolic outcomes in patients with non-PCOS.
Variables | PRL | Age | BMI | R | R2 | Adjusted R2 |
---|---|---|---|---|---|---|
Waist–hip ratio | −0.427 | −0.790 | 1.315 | 0.081 | 0.007 | −0.002 |
Basal serum LH (nmol/L) | −0.569 | −4.056** | −4.874** | 0.38 | 0.057 | 0.053 |
LH/FSH | −0.348 | −5.951** | −5.951** | 0.230 | 0.053 | 0.049 |
T (nmol/L) | 1.157 | −3.468* | 1.428 | 0.152 | 0.023 | 0.019 |
FPG (mmol/L) | −0.315 | 1.427 | 4.780** | 0.192 | 0.037 | 0.037 |
FINS (pmol/L) | 1.497 | −1.986 | 12.772** | 0.439 | 0.439 | 0.189 |
HOMA-IR(log10) | 1.319 | −1.483 | 12.514** | 0.430 | 0.185 | 0.182 |
HOMA-β | 0.945 | −2.221* | 9.423** | 0.343 | 0.118 | 0.114 |
Multiple regression analyses were performed with metabolic and hormonal outcomes as dependent variables and prolactin, age, and BMI as explanatory variables.
Data are presented as B-values (P-levels): *P < 0.05, **P< 0.001.